35 W 44th Street, 3rd Floor
New York City, NY 10036
2019 has the potential to be a significant year for microbiome medicines with numerous trial initiations & multiple important data readouts throughout the year. This event will feature key public & private companies leading development efforts in this field & will cover a variety of approaches to therapeutically targeting the microbiome.